The union government has approved Bharat Biotech’s intranasal vaccine, iNCOVACC. It will be used as a heterologous booster & will be available first in private hospitals. It will be included in COVID vaccination program from today, official sources have told the media.Nasal vaccine approved in India: Key points
The union government has approved Bharat Biotech’s intranasal vaccine, iNCOVACC. It will be used as a heterologous booster & will be available first in private hospitals. It will be included in COVID vaccination program from today, official sources have told the media.
